Dr. Samir D. Undevia
Claim this profileElmhurst Memorial Hospital
Studies Melanoma
Studies Ovarian Cancer
5 reported clinical trials
26 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
2Ovarian Cancer
BRCA1 positive
Affiliated Hospitals
Clinical Trials Samir D. Undevia is currently running
Immunotherapy + Chemotherapy
for Sarcoma
This phase III trial compares the effect of immunotherapy (pembrolizumab) plus chemotherapy (doxorubicin) to chemotherapy (doxorubicin) alone in treating patients with dedifferentiated liposarcoma (DDLPS), undifferentiated pleomorphic sarcoma (UPS) or a related poorly differentiated sarcoma that has spread from where it first started (primary site) to other places in the body (metastatic) or that cannot be removed by surgery (unresectable). Doxorubicin is in a class of medications called anthracyclines. Doxorubicin damages the cell's deoxyribonucleic acid (DNA) and may kill tumor cells. It also blocks a certain enzyme needed for cell division and DNA repair. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Adding immunotherapy (pembrolizumab) to the standard chemotherapy (doxorubicin) may help patients with metastatic or unresectable DDLPS, UPS or a related poorly differentiated sarcoma live longer without having disease progression.
Recruiting2 awards Phase 310 criteria
Biomarker-Guided Immunotherapy Discontinuation
for Melanoma
This trial uses drugs that boost the immune system to fight advanced melanoma that can't be surgically removed. It aims to see if doctors can safely shorten the treatment period by using imaging tests to guide decisions. Pembrolizumab and ipilimumab are immunotherapy drugs used to treat advanced melanoma, with pembrolizumab approved for younger patients and ipilimumab showing positive results in previous studies.
Recruiting1 award Phase 222 criteria
More about Samir D. Undevia
Clinical Trial Related10 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Samir D. Undevia has experience with
- Pembrolizumab
- Bilateral Salpingectomy
- Bilateral Salpingectomy With Oophorectomy
- Afatinib
- Binimetinib
- Capivasertib
Breakdown of trials Samir D. Undevia has run
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Samir D. Undevia specialize in?
Samir D. Undevia focuses on Melanoma and Ovarian Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Samir D. Undevia currently recruiting for clinical trials?
Yes, Samir D. Undevia is currently recruiting for 3 clinical trials in Elmhurst Illinois. If you're interested in participating, you should apply.
Are there any treatments that Samir D. Undevia has studied deeply?
Yes, Samir D. Undevia has studied treatments such as Pembrolizumab, Bilateral Salpingectomy, Bilateral Salpingectomy with Oophorectomy.
What is the best way to schedule an appointment with Samir D. Undevia?
Apply for one of the trials that Samir D. Undevia is conducting.
What is the office address of Samir D. Undevia?
The office of Samir D. Undevia is located at: Elmhurst Memorial Hospital, Elmhurst, Illinois 60126 United States. This is the address for their practice at the Elmhurst Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.